| | 288383-20-0 Basic information More.. |
| Product Name: | Cediranib | | Synonyms: | Cediranib;4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;Cadiranib (AZD2171);Cediranib(AZD2171);AZD2171;Recentin;Cadiranib;Cediranib R | | CAS: | 288383-20-0 | | MF: | C25H27FN4O3 | | MW: | 450.51 | | EINECS: | 670-946-2 | | Mol File: | 288383-20-0.mol |  |
Use
Cediranib is a drug for blocking angiogenesis, study on cervical cancer molecular targeted drug and clinical application progress, value of correlative biomakers in the understanding of tumor biology. Cediranib (AZD2171) inhibited VEGF-stimulated proliferation and KDR phosphorylation with IC50 of 0.4 and 0.5 nM, respectively.
- Cediranib
-
- US $35.00-84.00 / mg
- 2026-04-22
- CAS:288383-20-0
- Min. Order:
- Purity: 99.94%
- Supply Ability: 10g
- Cediranib
-
- US $10.00 / KG
- 2026-03-20
- CAS:288383-20-0
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 10 mt
- Cediranib USP/EP/BP
-
- US $1.10 / g
- 2025-11-18
- CAS:288383-20-0
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
|
|
288383-20-0
Recommend Suppliers |
|